Update It is now March 2021, and nine months after writing this piece below, saying that things have evolved would be an understatement. Focusing on the positive progress made to date, we have three approved vaccines in...
As the recent pandemic has made all too clear, organizations need to proactively prepare for the realities of a dispersed workforce, which is especially true for investor groups such as venture capital and private...
For decades, only venture capital (VC) firms, and very rarely, angels were able to invest in start-up companies developing life science—therapeutics, medical devices, diagnostics, and related—innovation. Anyone doing so...
Historically, innovative technologies discovered at universities, institutes and national labs have had two primary paths towards commercialization: (1) licensing to a large, pre-existing company; or, (2) licensing to...
FEATURED RESOURCES
